Skip to main content
. 2024 Jun 3;46(6):5595–5613. doi: 10.3390/cimb46060335
MS Multiple Sclerosis
CNS Central Nervous System
Relapsing-Remitting Multiple Sclerosis RRMS
Disease-modifying therapies DMT
Secondary Progressive Multiple Sclerosis SPMS
Primary Progressive Multiple Sclerosis PPMS
Nervous System NS
Myelin Basic Protein MBP
D-Galactose Gal
Coenzyme Q10 CoQ10
Matrix Metallo Proteases MMPs
Blood-Brain Barrier BBB
Tumor Necrosis Factor Alfa TNF-α
Interleukin-6 IL-6
Interleukin-4 IL-4
Superoxide Dismutase SOD
Glutathione Peroxidase GPx
Expanded Disability Status Scale EDSS
Cuprizone CPZ
Resveratrol RV
Nuclear Factor Erythroid 2-Related Factor 2 Nrf-2
Interleukin-1β IL-1β
Regulatory T cells Treg
Experimental Autoimmune Encephalomyelitis EAE
Epigallocatechin gallate ECGC
Body Mass Index BMI
Citicoline DCI
Phosphatidylcholine PC
Oligodendrocyte Precursor Cells OPCs
Boswellic Acid BA
Heme-oxygenase 1 HO-1
Ketogenic Diet KD
Mediterranean Diet MD
Reactive Oxygen Species ROS
Modified Atkins Ketogenic Diet MAKD
Healthy Subjects HS
Hexose-6-phosphate dehydrogenase H6PD